Cerebral blood flow velocity in acute schizophrenic patients: A transcranial doppler ultrasonography study

Stroke

Volumn 29, Issue 6, 1998, Pages 1149-1154

  Owega, Ammar ^a   Klingelhöfer, Jürgen ^b   Sabri, Osama ^a   Kunert, Hanns Jürgen ^a   Albers, Matthias ^a   Saß, Henning ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Blood flow velocity; Cerebral blood flow; Schizophrenia; Ultrasonography, Doppler

Indexed keywords

ADULT; ANTERIOR CEREBRAL ARTERY; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL DISEASE; MIDDLE CEREBRAL ARTERY; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 0344936094     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.6.1149     Document Type: Article

References (35)

1. DeLisi LE, Holcomb HH, Cohen RM, Pickar D, Carpenter WT, Morihisa JM, King AC, Kessler RM. Positron emission tomography (PET) in schizophrenic patients on and off neuroleptic medication. J Cereb Blood Flow Metab. 1985;5:201-206.
2. Gur RE, Resnick SM, Alavi A, Gur RC, Caroff S, Dann R, Silver FR, Saykin AJ, Chawluk JB, Kushner M, Reivich M. Regional brain function in schizophrenia, I: a positron emission tomography study Arch Gen Psychiatry. 1987;44:119-125.
3. Szechtman HJ, Nahmias C, Garnett ES, Firnau G, Brown GM, Kaplan RD, Cleghom JM. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psychiatry. 1988;45:523-532.
4. Ingvar DH, Franzén G. Distribution of cerebral activity in chronic schizophrenia. Lancet. 1974;2:1484-1486.
5. Catafau AM, Parellada E, Lomeña FJ, Bernardo M, Pavía J, Ros D, Setoain J, Gonzalez-Monclús E. Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO-SPECT patterns in young neuroleptic-naive patients with acute disease. J Nucl Med. 1994;35:935-941.
6. Dolan RJ, Bench CJ, Liddle PF, Friston KJ, Frith CD, Grasby PM, Frackowiak RS. Dorsolateral prefrontal cortex dysfunction in the major psychoses: symptom or disease specificity? J Neurol Neurosurg Psychiatry. 1993;56:1290-1294.
7. Hoyer S, Österreich K. Blood flow and oxidative metabolism of the brain in patients with schizophrenia. Psychiatria Clin. 1975;8:304-313.
8. Saunders C, Salles-Cunha S, Andros G. Transcranial Doppler: reproducibility of velocity measurements in the middle cerebral artery J Vasc Technol. 1990;14:30-32.
9. Sorteberg W, Langmoen IA, Lindegaard K-F, Nornes H. Side-to-side differences and day-to-day variations of transcranial Doppler parameters in normal subjects. J Ultrasound Med. 1990;9:403-409.
10. Larsen FS, Olsen KS, Hansen BA, Paulson OB, Knudsen GM. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke. 1994;25:1985-1988.
11. Alexandrov AV, Brodie DS, McLean A, Hamilton P, Murphy J. Burns PN. Correlation of peak systolic velocity and angiographic measurement of carotid stenosis revisited. Stroke. 1997;28:339-342.
12. Bishop CCR, Powell S, Rutt D, Browse NL. Transcranial Doppler measurements of middle cerebral artery blood flow velocity: a validation study. Stroke. 1986;17:913-915.
13. Dahl A, Lindegaard K-F, Russell D, Nyberg-Hansen R, Rootwelt K, Sorteberg W, Nornes H. A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity. Stroke. 1992;23:15-19.
14. Kirkham FJ, Padayachee TS, Parson S, Seargeant LS, House FR, Gosling RG. Transcranial measurement of blood velocities in the basal cerebral arteries using pulsed Doppler ultrasound: velocity as an index of flow. Ultrasound Med Biol. 1986;12:15-21.
15. Newell DW, Aaslid R, Lam A, Mayberg TS, Winn HR. Comparison of flow and velocity during dynamic autoregulation testing in humans Stroke. 1994;25:793-797.
16. Aaslid R, Markwalder T-M, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries J Neurosurg. 1982;57:769-774.
17. Huber P, Handa J. Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of the cerebral arteries. Invest Radiol. 1967;2:17-32.
18. Newell DW, Aaslid R. Transcranial Doppler: clinical and experimental uses. Cerebrovasc Brain Metab Rev. 1992;4:122-143.
19. Diehl RR, Berlit P. Funktionelle Dopplersonographie in der Neurologie. Heidelberg, Germany: Springer; 1996.
20. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
21. Gosling RG, King DH. Arterial assessment by Doppler-shift ultrasound. Proc Roy Soc Med. 1974;67:447-449.
22. Gosling RG. Doppler ultrasound assessment of occlusive arterial disease. Practitioner. 1978;220:599-609.
23. SAS® Version 6.12: SAS/STAT Software: Changes and Enhancements Cary, NC: SAS Institute Inc; 1996.
24. Gur RE, Gur RC, Skolnick BE, Caroff S, Obrist WD, Resnick S, Reivich M, Brain function in psychiatric disorders, III: regional cerebral blood flow in unmedicated schizophrenics. Arch Gen Psychiatry. 1985;42:329-334.
25. Silvestrini M, Cupini LM, Matteis M, Troisi E, Caltagirone C. Bilateral simultaneous assessment of cerebral flow velocity during mental activity J Cereb Blood Flow Metab. 1994;14:643-648.
26. Knecht S, Henningsen H, Deppe M, Huber T, Ebner A, Ringelstein E-B. Successive adaptation of both cerebral hemispheres during cued word generation. Neuroreport. 1996;7:820-824.
27. Klingelhöfer J, Sander D, Matzander G, Schwarze J, Boecker H, Bischoff C. Assessment of functional hemispheric asymmetry by bilateral simultaneous cerebral blood flow velocity monitoring. J Cereb Blood Flow Metab. 1997;17:577-585.
28. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Saß H, Büll U. Correlations of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet. 1997;349:1735-1739.
29. Andreasen NC, Rezai K, Alliger RJ, Swayze II VW, Flaum M, Kirchner P, Cohen G, O'Leary DS. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry. 1992;49:943-958.
30. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, Jones T, Frackowiak RSJ. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 1995;378:176-179.
31. Cleghorn JM, Franco S, Szechtman B, Kaplan RD, Szechtman H, Brown GM. Nahmias C, Garnett ES. Toward a brain map of auditory hallucinations. Am J Psychiatry. 1992;149:1062-1069.
32. Schröder J. Subsyndrome der chronischen Schizophrenie: Ein psychopathologisches Konzept im Spiegel bildgebender Verfahren. Heidelberg, Germany: University of Heidelberg; 1994. Thesis.
33. Freeman T, Karson CN. The neuropathology of schizophrenia: a focus on the subcortex. Psychiatr Clin North Am. 1993;16:281-293.
34. Frith CD, Friston J, Herold S, Silbersweig D, Fletcher P, Cahill C, Dolan RJ, Frackowiak RSJ, Liddle PF. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry. 1995;167:343-349.
35. Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, Missimer J, Angst J. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDGj. Eur Neuropsychopharmacol. 1997;7:9-24.